Billets de Michelle Dawson

Billet publié sur Twitter/X le 26/01/2023 06:44

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

Duke University, The Marcus Foundation (2021). Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder. ClinicalTrials.gov. Duke University.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Duke University, The Marcus Foundation (2021). Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder. ClinicalTrials.gov. Duke University.

Date de publication
24/02/2021
Identifiant
NCT04294290
Auteurs
Duke University, The Marcus Foundation
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Duke University
Source de métadonnées
clinicaltrials.gov

Résumé

This is a single site, prospective study of one intravenous infusion of human umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSC) in toddlers with autism spectrum disorder (ASD). Toddlers 18 to 48 months of age with a confirmed diagnosis of ASD will be eligible to participate. Diagnosis will be confirmed at the time of the eligibility visit at the Duke Center for Autism and Brain Development. All participants will receive a single intravenous dose of 2x106/kg hCT-MSC per kilogram at baseline. Assessments will be conducted at baseline and 6 months, with remote follow-up assessments at 12 months.

Ouvrir la source